Complementary and alternative medicine usage among cardiac patients: a descriptive study

BMC Complementary and Alternative Medicine

Mandreker Bahall¹ 

[1] Arthur Lok Jack Graduate School of Business, Max Richards Drive, Champ Fleurs, Mount Hope, Trinidad, Trinidad and Tobago

关键词: Treatment;    Side effects;    Complementary and alternative medicine;    Cardiac patients;   

Others  :  1172062
DOI  :  10.1186/s12906-015-0610-y

 received in 2014-08-28, accepted in 2015-03-13,  发布年份 2015

【 摘 要 】

Background

The use of complementary and alternative medicine (CAM) persists, despite the availability of conventional medicine (CM), modernisation, globalisation, technological advancement, and limited scientific evidence supporting CAM. People with cardiovascular diseases often use CAM, despite possible major adverse effects and lack of evidence supporting CAM claims. This study explored CAM use among cardiac patients, the types of CAM used, reasons and factors that influence its use, and the association between patient demographics and CAM use.

Methods

This cross-sectional quantitative study was conducted using quota sampling to survey 329 public clinic adult cardiac patients within the South–West Regional Health Authority (SWRHA) of Trinidad and Tobago. From 1 July 2012 to 31August 2012, each participant completed questionnaires, after consenting to participate. Data analysis included χ² tests and binary logistic regression.

Results

One hundred eighty-five (56.2%; standard error [SE] = 2.74%) patients used CAM. Herbal medicine was the most common CAM (85.9%; SE = 2.56%), followed by spiritual therapy/mind-body systems (61.6%; SE = 3.58%), physical therapy/body manipulation (13.5%; SE = 2.51%), alternative systems (8.1%; SE = 2.01%), and other methods (3.8%; SE = 1. 41%). The patients believed that CAM promotes health and wellness (79.5%; SE = 2.97%), assists in fighting illness (78.9%; SE = 3.00%), addresses the limitations of CM (69.2%; SE = 3.56%), alleviates symptoms (21.6%; SE = 6.51%), costs less than CM (21.6 %, SE = 3.03), and has fewer adverse/damaging effects than CM (29.7, SE =3.36), or they were disappointed with CM (12.4%, SE = 2.42). Ethnicity and religion were associated with CAM usage, but only ethnicity was a useful predictor of CAM use.

Conclusions

Complementary and alternative medicine use was high among cardiac patients (56.2%, SE = 2.74%), and associated with ethnicity and religion. Friends, family, and perceived mode of action influenced a patient’s use of CAM.

【 授权许可】

   
2015 Bahall; licensee BioMed Central.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Harris PE, Cooper KL, Relton C, Thomas KJ. Prevalence of complementary and alternative medicine (CAM) use by the general population: a systematic review and update. Int J Clin Pract. 2012; 66:924-39. http://www. ncbi.nlm.nih.gov/pubmed/22994327 . Accessed on 22 Feb 2015
• [2]Barnes PM, Bloom B, Nahin R. Complementary and alternative medicine use among adults and children: United States. CDC National Health Statistics Report #12. 2007. December 10, 2008. http://nccam.nih.gov/news/camstats/NHIS.htm. Accessed on 22 Feb 2015.
• [3]Posadzki P, Watson LK, Alotaibi A, Ernst E. Prevalence of use of complementary and alternative medicine (CAM) by patients/consumers in the UK: systematic review of surveys. Clin Med. 2013; 13:126-31.
• [4]Xue CC, Zhang AL, Lin V, Da Costa C, Story DF. Complementary and alternative medicine use in Australia: a national population-based survey. J Altern Complement Med. 2007; 13:643-50.
• [5]Metcalfe A, Williams J, McChesney J, Patten SB, Jette N. Use of complementary and alternative medicine by those with a chronic disease and the general population—results of a national population based survey. BMC Complement Altern Med. 2010; 10:58. doi: 10. 1186/1472-6882-10-58 . http://www.biomedcentral.com/1472-6882/10/58 . Accessed on 22 BioMed Central Full Text
• [6]Ong C-K, Banks B. Complementary and alternative medicine: the consumer perspective. The Prince of Wales’s Foundation for Integrated Health, London; 2003.
• [7]Tachjian A, Maria V, Jahangir A. Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol. 2010; 55:515-25.
• [8]Clement YN, Morton-Gittens J, Basdeo L, Blades A, Francis M, Gomes N et al.. Perceived efficacy of herbal remedies by users accessing primary healthcare in Trinidad. BMC Complement Altern Med. 2007; 7:4. BioMed Central Full Text
• [9]Moyne L, Stubbs R, Crowdy RE, Citrine W, Mackinnon P, Blacklock MG et al.. West India Royal Commission Report. Her Majesty’s Stationery Office, London; 1945.
• [10]Clement Y. Limited clinical evidence to support the integration of Caribbean herbs into conventional medicine. Focus Altern Complement Ther. 2011; 16:289-92.
• [11]Pagán JA, Pauly MV. Access to conventional medical care and the use of complementary and alternative medicine. Health Aff (Millwood). 2005; 24:255-62. http://content. healthaffairs.org/content/24/1/255.full . Accessed on 26 Feb 2015
• [12]American Heart Association. What is cardiovascular disease? http://www.heart.org/HEARTORG/Caregiver/Resources/WhatisCardiovascularDisease/What-is-Cardiovascular-Disease_UCM_301852_Article.jsp. Accessed on 26 Feb 2015.
• [13]de Souza MF M, Gawryszewski VP, Orduñez P, Sanhueza A, Espinal MA. Global burden of cardiovascular disease. Cardiovascular disease mortality in the Americas: current trends and disparities. Heart. 2012; 98:1207-12.
• [14]Grant SJ, Bin YS, Kiat H, Chang DH. The use of complementary and alternative medicine by the people with cardiovascular disease: a systematic review. BMC Public Health. 2012; 12:299. BioMed Central Full Text
• [15]Clement YN, Williams AF, Aranda D, Chase R, Watson N, Mohammed R et al.. Medicinal herb use among asthmatic patients attending a specialty care facility in Trinidad. BMC Complement Altern Med. 2005; 5:3. BioMed Central Full Text
• [16]Power M, Hopayian K. Exposing the evidence gap for complementary and alternative medicine to be integrated into science-based medicine. J R Soc Med. 2011; 104:155-61. doi: 10. 1258/jrsm.2011.100271 . http://www.dcscience.net/JRSM-Apr-2011-CAM.pdf . Accessed on −26 Feb 2015
• [17]National Center for Complementary and Alternative Medicine (NCCAM). Complementary, alternative, or integrative health: what’s in a name? http://nccam.nih.gov/health/whatiscam. Accessed on 26 Feb 2015.
• [18]Lin MC, Nahin P, Gershwin EM, Longhurst JC, Wu KK. State of complementary and alternative medicine in cardiovascular, lung, and blood research. Circulation. 2001; 103:2038-41.
• [19]Baldeosingh K. Cracking down on alternative medicine. Trinidad Express October 2, 2010. http://www.trinidadexpress.com/news/Cracking_down_on_alternative_medicine-104222959.html. Accessed on 26 Feb 2015.
• [20]Bodeker G, Kronenberg F. A public health agenda for traditional, complementary, and alternative medicine. Am J Public Health. 2002; 92:1582-91.
• [21]Hill FJ. Complementary and alternative medicine: the next generation of health promotion? Health Promot Int. 2003; 18:265-72.
• [22]Gordon Z. Health Minister: laws coming to regulate herbal business. Guardian. 2012 May 16. https://guardian.co.tt/news/2012-05-16/health-minister-laws-coming-regulate-herbal-business. Accessed on 26 Feb 2015.
• [23]Krejice RV, Morgan DW. Determining sample size for research activities. Educ Psychol Meas. 1970; 30:607-10.
• [24]National Center for Complementary and Alternative Medicine (NCCAM). Strategic object 3: increase understanding of ‘real world’ patterns and outcomes of CAM use and its integration into health care and health promotion. http://nccam.nih.gov/about/plans/2011/objective3.htm. Accessed on 26 Feb 2015.
• [25]Greenfield S, Pattison H, Jolly K. Use of complementary and alternative medicine and self tests by coronary heart disease patients. BMC Complement Altern Med. 2008; 8:47. BioMed Central Full Text
• [26]Krasuski RA, Michaelis K, Eckart RE. The cardiovascular patient’s perceptions of complementary and alternative medicine. Clin Cardiol. 2006; 29:161-4.
• [27]Nicdao EG, Ai AL. Religion and the use of complementary and alternative medicine (CAM) among cardiac patients. J Relig Health. 2014; 53:864-77.
• [28]Rabito MJ, Kaye DA. Complementary and alternative medicine and cardiovascular disease: an evidenced-based review. Evid Based Complement Alternat Med. 2013; 2013:672097. [ http://www. hindawi.com/journals/ecam/2013/672097 ] (Accessed on 26 Feb 2015)
• [29]Hussain S, Malik F. Integration of complementary and traditional medicines in public health care systems: challenges and methodology. J Med Plant Res. 2013; 7:2952-9. http://www. academicjournals.org/article/article1382454987_Hussain%20and%20Malik.pdf . Accessed on 26 Feb 2015
• [30]Nichol J, Thompson EA, Shaw A. Beliefs, decision-making, and dialogue about complementary and alternative medicine (CAM) within families using CAM: a qualitative study. J Altern Complement Med. 2011; 17:117-25.
• [31]Arslan IO, Ozer ZC, Kulakac O. Use of complementary and alternative medicine in cardiovascular diseases: a literature review. HealthMed. 2012; 6:2190-9.
• [32]White MA, Verhoef MJ, Davison BJ, Gunn H, Cooke K. Seeking mind, body and spirit healing—why some men with prostate cancer choose CAM (complementary and alternative medicine) over conventional cancer treatments. Integr Med Insights. 2008; 3:1-11.
• [33]Chu FY, Yan X, Zhang Z, Xiong XJ, Wang J, Liu HX. Features of complementary and alternative medicine use by patients with coronary artery disease in Beijing: a cross-sectional study. BMC Complement Altern Med. 2013; 13:287. http://www. biomedcentral.com/1472-6882/13/287 . Accessed on 26 Feb 2015 BioMed Central Full Text
• [34]Suarez T, Reese FL. Alternative medicine use, perceived control, coping, and adjustment in African American and Caucasian males living with HIV and AIDS. Int J Rehabil Health. 1997; 3:107-18.
• [35]Bekke-Hansen S, Pedersen CG, Thygesen K, Christensen S, Waelde LC, Zachariae R. Faith and use of complementary and alternative medicine among heart attack patients in a secular society. Complement Ther Med. 2012; 20:306-15. doi: 10. 1016/j.ctim.2012.03.003 . http://www.ncbi.nlm.nih.gov/pubmed/22863645 . Accessed on 26 Feb 2015
• [36]Lee GBW, Charn TC, Chew ZH, Ng TP. Complementary and alternative medicine use in patients with chronic diseases in primary care is associated with perceived quality of care and cultural beliefs. Fam Pract. 2004; 21:654-60.
• [37]Dharmananda S. Checking for possible herb–drug interactions. Institute for Traditional Medicine, Portland, OR; 2003.
• [38]Bent S, Goldberg H, Padula H, Avins AL. Spontaneous bleeding associated with Ginkgo biloba: a case report and systematic review of the literature: a case report and systematic review of the literature. J Gen Intern Med. 2005; 20:657-61. http://www. ncbi.nlm.nih.gov/pubmed/16050865 . Accessed on 26 Feb 2015
• [39]Ge B, Zhang Z, Zuo Z. Updates on the clinical evidenced herb–warfarin interactions. Evid Based Complement Alternat Med. 2014; 2014:957362. http://dx. doi.org/10.1155/2014/957362 . Accessed on 26-02-2015
• [40]Jiang X, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC et al.. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol. 2005; 59:425-32. doi: 10. 1111/j.1365–21 . http://www.ncbi.nlm.nih.gov/pubmed/15801937 . Accessed on 26 Feb 2015
• [41]Taki Y, Yokotani K, Yamada S, Shinozuka K, Kubota Y, Watanabe Y et al.. Ginkgo biloba extract attenuates warfarin-mediated anticoagulation through induction of hepatic cytochrome P450 enzymes by bilobalide in mice. Phytomedicine. 2012; 19:177-82. http://www. thefreelibrary.com/Ginkgo+biloba+extract+attenuates+warfarinmediated+anticoagulation...-a0282347268. Accessed on 17 Dec 2014
• [42]Paul JHA, Seaforth CE. Harmful plants in Caribbean folk medicine. Focus Altern Complement Ther. 2011; 16:261-5.
• [43]Harris WS, Miller M, Tighee AP, Davidson MH, Schaefer EJ. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis. 2008; 197:12-24. http://www. ncbi.nlm.nih.gov/pubmed/18160071. Accessed on 26 Feb 2015
• [44]Lee B, Tseng Y, Yen C, Lin P. Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial. Nutr J. 2013; 12:142. doi:10. 1186/1475-2891-12-142. http://www.nutritionj.com/content/12/1/142 . Accessed on 26 Feb 2015 BioMed Central Full Text
• [45]Joshipura KJ, Hu FB, Manson JE, Stampfer MJ, Rimm EB, Speizer FE et al.. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med. 2001; 134:1106-14.
• [46]Moats C, Rimm EB. Vitamin intake and risk of coronary disease: observation versus intervention. Curr Atheroscler Rep. 2007; 9:508-14. http://www. isom.eu/pdf/07MoatsRimmVitaminCVD.pdf . Accessed on 26 Feb 2015
• [47]JAMA and Archives Journals. Meta-analysis shows no heart benefits for folic acid supplements. Science Daily. 2010 Oct 12. http://www.sciencedaily.com/releases/2010/10/101011173302.htm. Accessed on 26 Feb 2015.
• [48]Liu EH, Turner LM, Lin SX, Klaus L, Choi LY, Whitworth J et al.. Use of alternative medicine by patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2000; 120:335-41.